❗️сегодня - отчеты после закрытия
🇺🇸#PLUG - Plug Power - 23:00мск
🇺🇸#NVAX - Novavax - 23:00мск
🇺🇸#EXPE - Expedia - 23:05мск
🇺🇸#SPCE - Virgin Galactic - 23:05мск
🇺🇸#BYND - Beyond Meat - 23:05мск
🇺🇸#VLDR - Velodine - 23:05мск
🇺🇸#GPRO - GoPro - 23:05мск
🇺🇸#CVNA - Carvana - 23:05мск
🇺🇸#SHAK - Shake Shack - 23:05мск
🇺🇸#VIR - Vir Biotechnology - 23:05мск
🇺🇸#FSR - Fisker - 23:10мск
🇺🇸#TRIP - Trip Advisor - 23:10мск
🇺🇸#MNST - Monster Beverage - 23:10мск
🇺🇸#GRPN - Groupon - 23:10мск
🇺🇸#PLUG - Plug Power - 23:00мск
🇺🇸#NVAX - Novavax - 23:00мск
🇺🇸#EXPE - Expedia - 23:05мск
🇺🇸#SPCE - Virgin Galactic - 23:05мск
🇺🇸#BYND - Beyond Meat - 23:05мск
🇺🇸#VLDR - Velodine - 23:05мск
🇺🇸#GPRO - GoPro - 23:05мск
🇺🇸#CVNA - Carvana - 23:05мск
🇺🇸#SHAK - Shake Shack - 23:05мск
🇺🇸#VIR - Vir Biotechnology - 23:05мск
🇺🇸#FSR - Fisker - 23:10мск
🇺🇸#TRIP - Trip Advisor - 23:10мск
🇺🇸#MNST - Monster Beverage - 23:10мск
🇺🇸#GRPN - Groupon - 23:10мск
🇺🇸#FSR #отчетность
Fisker
Q2 GAAP EPS of -$0.16.
Cash and cash equivalents of $962 million as of June 30, 2021 and zero debt.
Net cash used in operating activities totaled $28.1 million and cash paid for capital expenditures totaled $0.3 million.
Fisker
Q2 GAAP EPS of -$0.16.
Cash and cash equivalents of $962 million as of June 30, 2021 and zero debt.
Net cash used in operating activities totaled $28.1 million and cash paid for capital expenditures totaled $0.3 million.
🇺🇸#PLUG #отчетность
Plug Power
Q2 GAAP EPS of -$0.18 misses by $0.11.
Revenue of $124.56M (+83.0% Y/Y) beats by $13.35M.
Gross billings were $126.3M this quarter compared to $72.4M a year ago.
"Growth in the electrolyzer business is estimated to be up over 400% in 2021 versus 2020 and expected to continue to grow at robust levels through 2024," company statement.
Plug Power
Q2 GAAP EPS of -$0.18 misses by $0.11.
Revenue of $124.56M (+83.0% Y/Y) beats by $13.35M.
Gross billings were $126.3M this quarter compared to $72.4M a year ago.
"Growth in the electrolyzer business is estimated to be up over 400% in 2021 versus 2020 and expected to continue to grow at robust levels through 2024," company statement.
🇺🇸#VIR #отчетность
Vir Biotechnology
Q2 GAAP EPS of $0.46.
Revenue of $177.07M (+164.3% Y/Y)
Net income in the quarter was largely due to recognition of revenue related to the license granted to GSK under the Company’s 2021 GSK agreement.
Vir Biotechnology
Q2 GAAP EPS of $0.46.
Revenue of $177.07M (+164.3% Y/Y)
Net income in the quarter was largely due to recognition of revenue related to the license granted to GSK under the Company’s 2021 GSK agreement.
🇺🇸#VLDR #отчетность
Velodyne Lidar
Q2 Non-GAAP EPS of -$0.18 misses by $0.03;
GAAP EPS of -$0.42 misses by $0.12.
Revenue of $13.6M (-52.1% Y/Y) misses by $3.75M.
Reaffirmed full year 2021 revenue guidance of between $77 and $94 million vs. the $85.1 million consensus
Velodyne Lidar
Q2 Non-GAAP EPS of -$0.18 misses by $0.03;
GAAP EPS of -$0.42 misses by $0.12.
Revenue of $13.6M (-52.1% Y/Y) misses by $3.75M.
Reaffirmed full year 2021 revenue guidance of between $77 and $94 million vs. the $85.1 million consensus
🇺🇸#BYND #отчетность
Beyond Meat
Q2 Non-GAAP EPS of -$0.31 misses by $0.08;
GAAP EPS of -$0.31 misses by $0.09.
Revenue of $149.4M (+31.8% Y/Y) beats by $8.36M.
Gross margin of 31.7% vs. consensus of 30.9%.
Q3 net revenues to be in the range of $120M-$140M (consensus: $152.9M), an increase of 27% to 47% Y/Y.
Beyond Meat
Q2 Non-GAAP EPS of -$0.31 misses by $0.08;
GAAP EPS of -$0.31 misses by $0.09.
Revenue of $149.4M (+31.8% Y/Y) beats by $8.36M.
Gross margin of 31.7% vs. consensus of 30.9%.
Q3 net revenues to be in the range of $120M-$140M (consensus: $152.9M), an increase of 27% to 47% Y/Y.
🇺🇸#NVAX #отчетность
Novavax
Q2 GAAP EPS of -$4.75 misses by $1.50.
Revenue of $298.02M (+738.5% Y/Y) misses by $89.85M.
The company expects to file for Emergency Use Listing with the World Health Organization in August 2021.
⚠️задерживается с подачей заявки на одобрение на экстренное использование своей антиковидной вакцины - NVAX expects to submit for emergency use authorization to the U.S. FDA in Q4 2021 - this had previously been slated for Q3.
Novavax
Q2 GAAP EPS of -$4.75 misses by $1.50.
Revenue of $298.02M (+738.5% Y/Y) misses by $89.85M.
The company expects to file for Emergency Use Listing with the World Health Organization in August 2021.
⚠️задерживается с подачей заявки на одобрение на экстренное использование своей антиковидной вакцины - NVAX expects to submit for emergency use authorization to the U.S. FDA in Q4 2021 - this had previously been slated for Q3.
🇺🇸#SPCE #отчетность
Virgin Galactic
Q2 GAAP EPS of -$0.39 misses by $0.06.
Revenue of $0.57M beats by $0.44M.
Cash position remains strong, with cash and cash equivalents of $552 million as of June 30, 2021.
💥компания объявила о возобновлении продажи билетов после того, как увидела большой интерес на рейсы Unity 22. Цены будут начинаться с $450 тыс за место
Virgin Galactic
Q2 GAAP EPS of -$0.39 misses by $0.06.
Revenue of $0.57M beats by $0.44M.
Cash position remains strong, with cash and cash equivalents of $552 million as of June 30, 2021.
💥компания объявила о возобновлении продажи билетов после того, как увидела большой интерес на рейсы Unity 22. Цены будут начинаться с $450 тыс за место
🇺🇸#GRPN #отчетность
Groupon
Q2 Non-GAAP EPS of $0.33 beats by $0.32;
GAAP EPS of -$0.12 beats by $0.32.
Revenue of $265.9M (-32.8% Y/Y) beats by $10.97M.
Groupon
Q2 Non-GAAP EPS of $0.33 beats by $0.32;
GAAP EPS of -$0.12 beats by $0.32.
Revenue of $265.9M (-32.8% Y/Y) beats by $10.97M.
⚠️🇺🇸#печатныйстанок #инфляция #сша #tapering
сенатор Joe Manchin написал письмо Пауэллу, где выразил свою озабоченность по поводу инфляции и призвал ФРС начать сворачивание экстренного стимулирования
сенатор Joe Manchin написал письмо Пауэллу, где выразил свою озабоченность по поводу инфляции и призвал ФРС начать сворачивание экстренного стимулирования
⚠️🇺🇸🇨🇳#сша #китай #бизнес #геополитика
опрос SCMP: за последний год Китай перестал быть приоритетным направлением для американских компаний из-за ухудшающихся отношений между странами
опрос SCMP: за последний год Китай перестал быть приоритетным направлением для американских компаний из-за ухудшающихся отношений между странами